Sanofi Consumer Share Price Target 2025 to 2050: Do you know, Sanofi Consumer is one of the multibagger return stocks, which increased by up to 5.10% the last six months. Are you considering investing in Sanofi Consumer Healthcare India Ltd? If you are curious about the Sanofi Consumer share price target for 2025? Want to know its future Price target?
This guide will discuss the Sanofi Consumer share target for The Years 2025, 2026 to 2030, to 2050. Along with this, we will do a complete Fundamental analysis to help you make the right decision. Stay tuned with us for complete, in-depth research and forecasts.
Sanofi Consumer Healthcare India Ltd: Company Overview
The Sanofi Consumer Healthcare India Ltd is one of the prominent key players in the pharmaceutical and healthcare industry in India. The company was incorporated in 2023, engaging in the manufacture and trading of drugs & pharmaceutical products. SCHIL was formed by demerging from Sanofi India Limited to establish an independent consumer healthcare (CHC) business.
Sofi Consumer operates in the Consumer Healthcare (CHC) sector, providing self-care solutions across various health categories, including allergy relief, pain management, and wellness. It operates across a range of channels, including distributors, wholesalers, government institutions, hospitals, pharmacies, pharmacy chains, and e-commerce platforms. SCHIL also has various independent third-party manufacturers. They sell their products through independent distributors, primarily in India. It operates its business in 29 states of India and 2 overseas countries..
Key highlights
- The company’s major branded products are a) Pain relief (Combiflam®), b) Allergy care (Allegra®, Avil®), c) Essential vitamins (DePURA®).
- Market share of these branded products is Allergy (Allegra) ~8.2%, Pain (Combiflam) ~2.5%,
Physical wellness (DePura) ~1.5%, Allergy (Avil) ~6.3%. - The company’s major Clientele are Stockists, healthcare professionals, and government institutions.
- As per the Geographical Revenue Split – FY24, the company exports ~9% and Domestic ~91%.
Sanofi Consumer Healthcare India Ltd Historical Share Price Performance
The Sanofi Consumer Healthcare India Limited was listed on September 13th 2024, on the stock exchanges of BSE and NSE. This stock is a multibagger stock, providing a huge return to its investors. It had increased by ₹546.00 (11.13%) since the listing on the Stock Exchange. From January 2025 to 1 July 2025, the company stock increased by ₹539.7 (11.0%). Here is the return of the JFSL over the period:
| Period | Returns |
| Past 6 Months | +540.90 (11.02%) |
| Past 1 Year | +546.00 (11.13%) |
| Past Five Years (5Y) | +546.00 (11.13%) |
| All Time | +546.00 (11.13%) |
Sanofi Consumer Share Price Target 2025
The company started its business in the Indian market with ₹ 4,908.6 at the start of 2025 on 1st January. After that, the share price faced a downfall in the next 2 months by 28th February 2025 and dropped its shares by ₹4,552.40. But after that, the company has continuously grown its share and touched a maximum share price of ₹5,750 in the middle of 2025 on 30 June. The growing nature of the company’s share and the anticipation of crossing the target of $6000 by the end of 2025.
| Sanofi Consumer Share Price in 2025 | Amount in Rupees |
| Minimum Share Price | ₹5,001 /- |
| Maximum Share Price | ₹6,000 /- |
Sanofi Consumer Share Price Target 2026
After comparing last year’s data of the Sanofi consumer, it is visible that the company touched a minimum share of Rs. 4,211.55 on 8th October 2024 and the maximum share in the past 52 weeks was reported on 30 June 2025 with ₹5 5,750 Investors can see the same agreement in 2026 and can expect the share price of the company to range between ₹5990 and to maximum of ₹7200.
| Sanofi Consumer Share Price in 2026 | Amount in Rupees |
| Minimum Share Price | ₹5,990 /- |
| Maximum Share Price | ₹7,200 /- |
Sanofi Consumer Share Price Target 2027
The Healthcare business is growing fastly at below has most families are now educated about the importance of health and wealth to maintain their health. The total market cap of the company is 12,392.78 crore rupees in 2025, which is expected to grow further and include more customers in their Health Care plans. The financial reports of the company suggest that the share price will range between ₹6900 and to maximum of ₹8210 by the end of December 2027.
| Sanofi Consumer Share Price in 2027 | Amount in Rupees |
| Minimum Share Price | ₹6,900 /- |
| Maximum Share Price | ₹8,210 /- |
Read Also: DEN Networks Share Price Target 2025 to 2050
Sanofi Consumer Share Price Target 2028
Promoters and Groups of the Sanofi Consumer India Ltd are maintaining a stable holding of share price with 60.40% shares. Public investors have access to 39.60% shares of the company for more than 3 quarters. This strong possession of shareholding indicates that the company is not under pressure.
So, the company has 100% rights to take necessary steps to grow the business, which will range from a share price between minimum share price of ₹8009 to a maximum share price of ₹9,505 in 2028.
| Sanofi Consumer Share Price in 2028 | Amount in Rupees |
| Minimum Share Price | ₹8,009 /- |
| Maximum Share Price | ₹9,505 /- |
Sanofi Consumer Share Price Target 2029
The share price of the company is increasing according to inflation and the price of the rupee in India. For example, shareholders are receiving 11.03% returns in the past 6 months from the company, but in the past 5 years, the company has provided 13% Returns to investors.
So they are offering a stable return to their customers annually, which will further provide the same benefits to long-term investors and can arrange a share price of a minimum of ₹9300 to a maximum of ₹10,900 in 2029.
| Sanofi Consumer Share Price in 2029 | Amount in Rupees |
| Minimum Share Price | ₹9,300 /- |
| Maximum Share Price | ₹10,900 /- |
Sanofi Consumer Share Price Target 2030
2030 is a key here for inventors as most of the investors are planning to invest their money for the next 5 years in the share market. The assets of the company are approximately triple the liabilities. Currently, the company is managing total assets worth ₹ 431 crores, and liabilities are ₹158 crores in the December quarter of 2024.
This healthy balance of Assets and liabilities is good for providing maximum returns to customers. Investors can see a range of share prices between rupees 10,890 to ₹12,340 in 2030.
| Sanofi Consumer Share Price in 2030 | Amount in Rupees |
| Minimum Share Price | ₹10,890 /- |
| Maximum Share Price | ₹12,340 /- |
Sanofi Consumer Share Price Target 2035
The long-term investment goal in Sanofi Consumer Private Limited is to anticipate a share price target of a minimum of ₹₹13,500 to a maximum of ₹15,650 in 2035
| Sanofi Consumer Share Price in 2035 | Amount in Rupees |
| Minimum Share Price | ₹13,500 /- |
| Maximum Share Price | ₹15,650 /- |
Sanofi Consumer Share Price Target 2040
The healthcare sector, especially the health insurance sector, has the potential to become a big market player in stocks, as governments are also promoting health insurance programs in their workplaces for ordinary citizens.
However, companies need to modify their premiums according to the government norms, but if they modify them, then they will get a huge benefit from the government and will impact on market performance. Share of Sanofi Consumer Private Limited can range between ₹ to ₹ in 2040.
| Sanofi Consumer Share Price in 2040 | Amount in Rupees |
| Minimum Share Price | ₹17,260/- |
| Maximum Share Price | ₹19,435 /- |
Read Also: Trent Share Price Target 2025 to 2050
Sanofi Consumer Share Price Target 2045
Current market reports of Sanofi Consumer Private Limited are expecting the share price of the company to grow in the next 20 years, with a share price of ₹ to ₹ in 2045
| Sanofi Consumer Share Price in 2045 | Amount in Rupees |
| Minimum Share Price | ₹21,000 /- |
| Maximum Share Price | ₹24,750 /- |
Sanofi Consumer Share Price Target 2050
It is difficult to forecast the share price of a company for such a long duration, but shareholders can expect to see a minimum price of ₹₹26,840 to a maximum of ₹29,980 in 2050.
| Sanofi Consumer Share Price in 2050 | Amount in Rupees |
| Minimum Share Price | ₹26,840 /- |
| Maximum Share Price | ₹29,980 /- |
Read Also: Cochinship Share Price Target 2025 to 2050
Overview of Sanofi Consumer Share Price Target 2025 to 2050
| Years | Share Price (Rs.) |
|---|---|
| 2025 | ₹5,001 to ₹6,000 |
| 2026 | ₹5,990 to ₹7,200 |
| 2027 | ₹6,900 to ₹8,210 |
| 2028 | ₹8,009 to ₹9,505 |
| 2029 | ₹9,300 to ₹10,900 |
| 2030 | ₹10,890 to ₹12,340 |
| 2035 | ₹13,500 to ₹15,650 |
| 2040 | ₹17,260 to ₹19,435 |
| 2045 | ₹21,000 to ₹24,750 |
| 2050 | ₹26,840 to ₹29,980 |
Sanofi Consumer Fundamental Analysis
| Metric | Value |
| Market Cap | ₹ 12,437 Cr. |
| 52-Week High | ₹ 5,954 |
| 52-Week Low | ₹ 4,212 |
| Face Value | ₹ 10.0 |
| Book Value | ₹ 119 |
| Return on Equity (ROE) | 83.8 % |
| Return on Capital Employed (ROCE) | 111 % |
| P/B Ratio | 48.04 |
| P/E Ratio | 77.93 |
| Dividend Yield | 1.01% |
| Sales Growth (YoY) | -22.11 (March 2025) |
| Profit Growth (YoY) | -20.26 (March 2025) |
| Promoter Holding | 60.40% |
| Net Profit Margin | 28.97 |
| Debt-to-Equity Ratio | 7.4% (March 2025) |
Sanofi Consumer Financial Reports
| Sector | Year (March 2025) |
| Revenue | ₹173 crore |
| Expense | ₹109 Crore |
| Profit Before Tax | ₹67 Crore |
| Net Profit | ₹50 Crore |
Sanofi Consumer Peer Comparison
| Stock Name | M. Cap (Cr) | 1 Yr Return (%) | P/E (TTM) | PB Ratio |
|---|---|---|---|---|
| Neuland Laboratories Ltd | 152.39 | +53.91% | 58.59 | 10.92 |
| Blue Jet Healthcare Ltd | 146.33 | +101.93% | 47.94 | 15.84 |
| Sanofi India Ltd | 142.64 | -5.47% | 35.98 | 18.60 |
| Sanofi Consumer Healthcare India Ltd | 124.85 | NaN% | 74.18 | 54.37 |
| Alivus Life Sciences Ltd | 122.45 | +12.52% | 25.21 | 4.82 |
| Granules India Ltd | 118.69 | -1.11% | 23.67 | 3.46 |
| Marksans Pharma Ltd | 117.14 | +57.84% | 30.78 | 5.13 |
Sanofi Consumer Shareholding Pattern
| Category | Share Holding (%) |
|---|---|
| Promoter | 60.4% |
| Mutual Funds | 15.09% |
| Other Institutions | 10.39% |
| Public | 9.56% |
| FII | 4.52% |
Conclusion
If you want to add a multibagger return and a high-growth potential stock, then Sanofi Consumer Healthcare India Ltd. stocks are suitable for you. From 2025 to 2030, it will boost your portfolio, and also has the potential to cover up all the losses you have made. The company has an amazing financial performance. In the last few years, it has improved overall sales and profit growth.
Howevre, in the previous quarter, the sales and profit growth decreased, but there is a strong possibility to cover up in the next quarter. This is the best stock for the long term. Investors should focus on all the trends and perofmed own analysis before investing.
Disclaimer: Stock market investments are subject to risks. The provided information is given for educational purposes. The predictions provided are based on research and past trends, and investors should do their analysis before making financial decisions. Make sure to ask and consult with industry experts and investors.